Neogen CORP 10-Q quarterly reports

Neogen Corporation reported a revenue decrease for the third quarter of fiscal year 2026, driven by divestitures, while also announcing plans to sell its genomics business.

Neogen Corporation reported a net income of $20.4 million for the first six months of fiscal year 2026, primarily driven by a divestiture gain, despite a 3% revenue decline and ongoing operational inefficiencies.

Neogen Corporation reported a net income of $36.3 million for Q1 FY2026, primarily driven by a $76.4 million gain from the sale of its Cleaners & Disinfectants business, despite a 4% revenue decline and an operating loss.

Neogen Corporation's Q3 2025 results reveal a net loss driven by a significant goodwill impairment charge and ongoing integration challenges, despite some revenue growth in specific product lines.

Neogen Corporation's Q2 2025 results reveal a substantial net loss primarily driven by a $461.4 million goodwill impairment charge in its Food Safety segment.

Neogen Corporation's first quarter of fiscal year 2025 saw a decrease in revenue and a net loss, impacted by foreign exchange headwinds and lower sales volumes.

Neogen Corporation's Q3 results show a net loss of $2 million, impacted by integration costs, despite a revenue increase of 5% year-over-year.